LinkedIn image ad examples

Sama matka, mutta erilainen tarina 🩵 Attendo-kotien ikäihmisten läheisten rooli on saanut keskusteluissa ansaitsemaansa huomiota. Mutta pitkä matka kotiin ei kosketa vain heitä. Tällä kertaa tarinan kertoo Ulla, mielenterveys- ja päihdekuntoutujan läheinen. Sairaus voi pakottaa ihmisen jättämään kotinsa nopeasti. Läheinen joutuu oppimaan kaiken kerralla. Näin kävi kuvassa olevalle Ullalle, joka on 65-vuotias mielenterveys- ja päihdekuntoutujan sisko, läheinen ja edunvalvoja. Hän kertoo, että raskainta oli tutustua siskon sairauteen. Ullan sanat videollamme jäivät mieleeni: “Kyllä mä tämän jaksoin, koska oli sisko kyseessä.” Mielenterveys- ja päihdeongelmat koskettavat monia perheitä, mutta läheisistä puhutaan vähän. He opettelevat uusia rooleja, kantavat jatkuvaa huolta ja hoitavat asioita, joihin kukaan ei ole heitä valmentanut. Usein he tekevät sen yksin. Attendo-kodissa ammattilaiset kantavat arjen, jonka tavoitteena on toipuminen ja jaloilleen pääseminen - ja Ulla saa olla taas sisko. Kun läheinen saa tukea, hän jaksaa kulkea rinnalla pidempään. Hän jaksaa kannatella myös omaa arkeaan: työtä, perhe-elämää, vapaaehtoistoimintaa, mitä arki kullekin on! Toivomme, että päättäjät huomioisivat läheiset aina, kun he päättävät palveluista. Siksi olemme nostaneet tänä syksynä läheiset keskiöön. Pitkä matka kotiin – se tiivistää hyvin. Kerromme läheisten tarinoita, koska heidän matkansa alkaa pitkältä ennen kuin asukas muuttaa Attendo-kotiin. Ullan matka on yksi niistä. 💙 #EnnenKaikkeaOlemmeKoti @AttendoSuomi

Healthcare workers have a high risk of exposure to respiratory viruses such as flu and COVID-19. The flu vaccine is recommended for all healthcare workers. The COVID-19 vaccine is recommended for some healthcare workers at risk of serious illness. Any healthcare worker who wants a COVID-19 vaccine can get one. Both vaccines are: ➡️ safe and effective ➡️ free for healthcare workers ➡️ available from participating GPs, pharmacies and staff vaccination clinics For more information, visit: https://bit.ly/4jfEqqA

qEV: Repeatable extracellular vesicle (EV) isolation, established across the sample types you work with.

Top-up your protection this winter. The flu vaccine is recommended for all healthcare workers. The COVID-19 vaccine is recommended for some healthcare workers at risk of serious illness. Any healthcare worker who wants a COVID-19 vaccine can get one. Find your local vaccination clinic: https://bit.ly/3TON8BT

qEV columns support samples from 150 µL to industrial volumes. Our complete ecosystem supports you at every stage of scale-up.

Vi vet att du har mycket på jobbet. Transcribe underlättar din vardag. Konvertera röstmeddelanden automatiskt till text i Aurora teleQ. Administrationstiden går ner – och du får mer tid till dina patienter. Nu har Transcribe ännu högre träffsäkerhet på läkemedelsnamn. Ytterligare ett steg mot en smidigare arbetsdag.

Hur många röstmeddelanden lyssnar du på varje dag? 👀 Spara tid, och få en snabb överblick med Transcribe. Låt dina röstmeddelanden tryggt transkriberas med hjälp av AI inom Aurora teleQ. För en smidigare och effektivare arbetsdag.

Different diseases. Different challenges. One diagnostic platform. Autoimmunity doesn't follow a single path. Neither should laboratory diagnostics. From rheumatology to hepatology, from vasculitis to thyroid disorders, every clinical area brings its own diagnostic challenges. What if you could address them all with the flexibility of MONOTEST technology? With its broad autoimmune assay portfolio, CHORUS EVO combines singleplex and multiplex testing with the flexibility of the MONOTEST format, supporting different diagnostic needs on a single platform. 🔬 One platform. Singleplex & Multiplex. MONOTEST flexibility. Explore Autoimmunity with DIESSE.

Paper and spreadsheets don't scale into GMP. See how CDMO Bend Bioscience connected inventory, workflows and quality in one platform.

What has 2026 revealed about organisational readiness? Access survey findings from top crisis, security, and risk leaders.

Is your organisation prepared to navigate unexpected global disruptions? Download our latest whitepaper for real-world insights and risk mitigation strategies from recent security escalations.

We asked nearly 400 people in pharma where they actually are with validated AI. Only 15% of respondents have it running in GxP. That single number sums up the Validated AI for Pharma Summit better than any recap could. Over 600 registrations, nearly 400 attendees from 38 countries, and people stayed for an average of nearly 3 hours. Nobody watches 3 hours of a virtual conference unless they're looking for something they haven't found elsewhere. Four things I took away: 1️⃣ The real question isn't "is the AI validated?", it's "what exactly are we validating?" The liveliest debate of the day: do you validate the model, or the code it produces? One team shared that in early tests, AI-driven code review surfaced several times more issues than human review of the same human-written code. That reframes the whole conversation. 2️⃣ Trustworthy AI starts with trustworthy data. Chris Decker (CDISC) opened with it, and the audience confirmed it, data quality and standards came back as the #1 blocker to calling a setup validated. 3️⃣ Sovereignty is not compliance. Hosting a model in Europe, or on your own hardware, doesn't hand you GxP. It moves the assurance work in-house. 4️⃣ The hardest problem is organisational, not technical. A third of respondents said nobody clearly owns AI adoption at their company. Which explains why so many pilots never become production. Thank you to every speaker: CDISC, Novartis, Eli Lilly and Company, PHUSE, Domino Data Lab, eClinical Solutions, ERA Sciences, HealthtechPartners 42, Pharma Law Solutions and to everyone who turned the chat into the best session of the day. We'll be back, and bigger. If validated AI is on your 2027 roadmap, follow along, the next one is already taking shape. 👉 Check for recordings: https://lnkd.in/dA4Qy5wF #PharmaAI #GxP #ValidatedAI #ClinicalDataScience

Many clinical setbacks can be traced back to decisions made during discovery. Join experts from Roche and IQVIA Laboratories to explore how human-relevant biology, translational science and clinic-informed discovery can help teams prioritize stronger candidates, identify risk before trials begin, and improve confidence in discovery decisions. Join the conversation so you can apply the same rigor, borrow what works and give your decision-making the authority it deserves. Register now: https://hubs.ly/Q04BrXnd0

Primary care works better when your doctor isn’t watching the clock. That’s the idea behind Complete Concierge Care. Each of our physicians maintains a deliberately small panel, which makes room for the things standard care often can’t: 24/7 access by email and cell, same or next-day sick visits, and an actual person answering when you call. We’re in-network with Medicare and most commercial plans. If you’ve been curious how concierge medicine actually works, we’re hosting two info sessions where you can meet our physicians and ask anything: In person: Wednesday, November 4, 5–7 PM · Hunter’s Bar and Grill, Potomac, MD Virtual: Tuesday, November 17, 6 PM · meeting link sent after RSVP Both sessions cover the same material. Choose whichever is easiest, and come meet the team.

The best care starts with a doctor who knows you. Not your chart glanced at at the door, but you — your history, your goals, the context that a rushed visit never has time for. That’s what Complete Concierge Care is built around: physicians with small panels and the time to build a real relationship, plus 24/7 access and same or next-day visits when you need them. Meet our physicians and see if it’s the right fit for you at one of two info sessions: In person — Wednesday, November 4, 5–7 PM · Hunter’s Bar and Grill, Potomac, MD Virtual — Tuesday, November 17, 6 PM · link sent after RSVP Both sessions are the same. Choose whichever is easiest.

Some of the most expensive mistakes in drug development aren't made in the clinic. They're made much earlier during discovery. Hear experts from Roche and IQVIA Laboratories discuss how human-centric approaches can help strengthen candidate selection and reduce downstream risk. Register now: https://hubs.ly/Q04BrWNX0

This Wednesday at 11am ET / 8am PT, the Climb team goes live. If your team runs non-GLP discovery in vivo work, and your studies live in spreadsheets or a tracker someone built years ago, this session is for you. ✅ Study designers and directors: configure a novel design, then amend it mid-study without a rebuild ✅ Technicians and research associates: see scheduling and structured data capture from scanners and scales ✅ Heads of discovery and in vivo ops: see how quickly a new design can be up and running, without building a system yourself Join us for this interactive session to see how Climb can support and manage your novel study designs. Register now: https://lnkd.in/eAjq8wbp #InVivo #Biotech #DrugDiscovery

Ein Drittel unserer Unternehmensgeschichte trägt auch Daniels Handschrift. ✍️ Seit 25 Jahren ist Daniel Teil von GEERS und hat in dieser Zeit nicht nur viele Entwicklungen miterlebt, sondern selbst mitgestaltet. Heute leitet er unsere Aus- und Weiterbildung und gibt seine Erfahrung und sein Wissen an die nächsten Generationen im #TeamGEERS weiter. 🚀 Ein Weg, der zeigt, wie viel entstehen kann, wenn Menschen über viele Jahre gemeinsam wachsen, Verantwortung übernehmen und sich immer wieder weiterentwickeln. Gerade zu unserem 75. Jubiläum wird deutlich: Unsere Geschichte besteht nicht nur aus Meilensteinen und Zahlen. Sie besteht vor allem aus den Menschen, die GEERS jeden Tag prägen. Umso mehr bedeutet es uns, dass Daniel GEERS nach all diesen Jahren als berufliche Heimat beschreibt. Danke, Daniel, für 25 Jahre #TeamGEERS und für Deinen Beitrag zu unserer gemeinsamen Geschichte. 💚 #75JahreGEERS #Hörakustik #Karriere #GemeinsamGewachsen

Brilliant to see Alyson Meister and the team at IMD leading the way in making wellbeing and resilience a core part of leadership development. The Financial Times article, how business schools teach leaders to beat burnout, highlights an important shift in how we think about leadership and performance. Rather than simply expecting leaders to cope with ever-increasing pressure, the focus is moving towards understanding stress, managing energy and building habits that support sustainable high performance. What particularly stands out is how IMD is putting this into practice, helping executives understand their own physiological responses to stress and recovery, and using those insights to make better decisions about how they work and live. This is exactly the kind of thinking we need more of. High performance shouldn't come at the expense of health and wellbeing. Alyson is doing a fantastic job of bringing this conversation into the mainstream and helping organisations recognise that wellbeing isn't a nice-to-have or an add-on. It's fundamental to effective leadership and long-term performance. At Firstbeat Technologies, we're proud to see physiological data helping bring greater understanding to the relationship between stress, recovery and performance. A great example of science, education and technology coming together to make a real difference. Read the article in the Financial Times: How business schools teach leaders to beat burnout https://lnkd.in/e7HB5R25 #Leadership #Wellbeing #Burnout #Resilience #Firstbeat #SustainablePerformance

Cell counting migration can become complicated fast — especially when teams need confidence in comparability across instruments and workflows. Vi-CELL BLU 2.0 software introduces expanded declustering options, enhanced image processing, improved edge detection and segmentation, and adjustable parameters to give labs greater flexibility when working with complex samples. Because cell counting software should support your workflow — not force your workflow to change. Explore Vi-CELL BLU 2.0 software flexibility: https://becls.co/4gaz0Kn

A CRO with 500 CRAs and the median 22% turnover refills about 110 seats a year. Each stays empty for 1.6 months. That’s roughly 15 monitors missing all year, before you add a single new seat.

🧪 Join our live webinar to meet the AI agents everyone in life sciences is talking about. Nearly half of pharma and biotech organizations are using or assessing AI agents, yet only 5% of labs have agentic AI in production. Cenevo product managers Michael Wood and Ilya Letnik will show what agentic AI really looks like in a lab. You’ll see agents that are already working inside labs today and ready to integrate into yours, followed by a live Q&A. Can’t make it? Register and we’ll send you the recording. Tuesday, November 17th, 2026 07:00 AM PT | 10:00 AM ET | 3:00 PM GMT Save your seat 👇

The distance between commercialization and care is where cell and gene therapy experience makes all the difference.

With a broad market view and sharp patient focus across key markets, we deliver CGTs with precision from promise to patient.